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In 1913 Richard Broadman, a lawyer from Jersey City, New Jersey, wrote to the 
Rockefeller Institute of Medical Research (RIMR) with an urgent inquiry.  He and his wife had 
just come into possession of mattresses used during the care of his wife’s aunt, who had died 
after a long illness a decade earlier.  Broadman feared that it might pass the illness to those who 
used the mattress in the future (although this had not prevented him from allowing the household 
maids to use it).  Amidst widespread concern over germ theories of disease in the early twentieth 
century, this was perhaps not remarkable   What was remarkable, was what disease Broadman 
wrote about to assuage his wife’s concerns, querying the staff of the Institute if there was a risk 
from “the danger of communication of the disease of cancer … whether there is any danger 
lurking in the use of these mattresses.”  Broadman himself was skeptical, but only because he 
doubted cancer “germs” could have survived in the mattress, not because he doubted the 
existence of such germs themselves!
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Broadman might have credited this theory, and written to the RIMR for advice, since in 
1911 RIMR researcher Peyton Rous famously observed the existence of “non-filterable” 
particles which appeared to be capable of transmitting tumors from one chicken to another.  
These “non-filterable” particles, later identified as viruses, were the objects of fierce controversy, 
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but also intense study.  As Ton van Helvoort and Eva Becsei Kilborn have discussed, Rous’s 
initial discovery that some “non-filterable” substance could be extracted from the tumors of one 
chicken and used to cause tumors in others, faced considerable difficulties despite the enthusiasm 
for germ theories of disease at the beginning of the twentieth century.
2
  The concept of a virus 
was poorly understood and many medical researchers doubted the applicability of animal models 
of cancer to humans.  However, interest in tumor viruses, revived with the discovery of 
mammalian papilloma viruses in the 1930s, accelerated rapidly in the 1950s thanks to 
enthusiasm generated by the success of the polio vaccine and new instrumentation, which helped 
stabilize the definition of viruses as objects, not vaguely defined “factors” or “substances.” 
  In a series of essays and articles Jean-Paul Gaudillière has sketched how cancer virus 
research benefitted from the emerging infrastructure of animal models used for chemotherapy 
research and the instrumentation of early molecular biology.
3
 By the 1960s cancer virus research 
became the center of what Life magazine called a “super program” of directed research uniting 
government, academia, and industry to produce a vaccine once a virus was identified in a human 
cancer.
4
  Concurrently, as Daniel Kevles has described, work on Rous’s substance (now called 
Rous Sarcoma Virus or RSV) advanced using tissue culture techniques originally developed for 
polio research.
5
  The effort to understand the process of viral reproduction resulted in the 1970 
discovery of reverse transcriptase, which showed how RNA-based viruses like RSV could 
transform cellular DNA.  When President Nixon lobbied for legislation vastly expanding cancer 
research in 1971, cancer virus research was one of, if not the most, exciting area discussed.  
However, this excitement soon created a crushing burden of expectations when no human cancer 
viruses appeared.  Then, in 1976, work on how RSV transformed infected cells resulted in the 
discovery of cellular oncogenes, leading to a rush out of viruses and into molecular genetics.  In 
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the 1990s, cancer virus research was portrayed as a detour away from the discovery of 
oncogenes.
6
  More recently the development of the Human Papilloma Virus vaccine to prevent 
cervical cancer indicates, as the editors of Science have recently suggested, that the historical 
legacy of cancer virus is undergoing a reassessment.
7
  
Broadman’s letter reminds us that these concerns about cancer viruses were not limited to 
a narrow community of laboratory researchers, but were taken up by the general public as well.  
My dissertation, “Cancer Viruses and the Construction of Biomedicine in the United States, 
1900-1980,” examines the history of cancer virus research as a critical juncture point in the 
history of biomedicine for laboratory science, public health, and popular expectation.  Moreover, 
cancer virus research, as my brief overview suggests, was a key area of work for figuring out the 
relationship between individual biomedical researchers, philanthropies, and the Federal 
government in cancer research during the middle of the twentieth century.  Ironically, cancer 
virus research, a prime area for the intersection of politics and science, has sometimes been 
neglected on political grounds.  Robert Proctor pointedly excluded the cancer viruses from his 
Cancer Wars (1995) on the grounds that they were a distraction from the environmental origins 
of most cancers.
8
  While historians such as Gaudillière or Ilana Löwy have started to bridge the 
divide between culture and experimental practices in the history of cancer, their works are in the 
minority and suggest the dividends of further work using this approach. 
  I thus approached my research at the Rockefeller Archive Center (RAC) with 
considerable excitement.  With the assistance of Lee Hiltzik and Cathy Brennan, I determined 
that the RAC not only holds some of the papers of prominent cancer researchers such as Peyton 
Rous or Richard Shope, but also those of leading centers of biomedical and cancer research such 
as the Rockefeller University (RU) and Memorial Sloan-Kettering Cancer Center (MSKCC).  
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These institutions, along with the Rockefeller family’s philanthropic activities, provide a unique 
vantage point to observe the scientific, public, and governmental facets of cancer research, and 
virus research in particular.  The diffuse nature of these materials, however, also makes it 
difficult to attribute coherence to my findings in the RAC.  Rather than attempt this, I will 
discuss one of the major themes that my research has followed: the relationship between 
experimental cancer research and public opinion.  It provides a site for bridging what the 
historian David Cantor has termed the “yawning” gap between social and intellectual histories of 
cancer research.
9
  In particular, many histories of cancer approach the relationship between 
researchers and the public as if public reception of these discoveries could only distort scientific 
findings.  Instead, I think that it is far more productive to think about the interplay between 
scientific and popular views of cancer research, with cancer virus research serving as an 
exemplary example of the tensions that attended cancer research in the middle of the century. 
“Almost all public health work involves a large amount of propaganda for public 
education,” the minutes of the Commonwealth Fund (CF) declared in December of 1919.  To 
further that end, a new grant application from the American Cancer Society for the Control of 
Cancer (the future American Cancer Society), for the “education of the laity” met with the CF’s 
approval.
10
  During the early twentieth century, anticancer efforts aimed to strike a balance 
between raising awareness and negotiating widespread fear and reticence concerning the disease.  
The Society made the construction of its field organization a key priority as it took shape during 
the 1920s.
11
  A Society Field Organizer foresaw that the control of cancer would only arrive after 
the “education of every single adult of the community.”12 
Alongside public education and fundraising, however, there was also concern with 
prompting too great a public reaction.  The idea of infectious human cancer viruses was often 
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implicated in concerns of this kind, which also displayed a tension between the biomedical 
research community and the public in the reception of research results.  For example, RIMR 
personnel resisted enthusiasm over the announcement by a British researcher, Wiliam Gye, that 
he had identified a chicken tumor virus.  One of Rous’s colleagues, James Murphy, appealed to 
the London Times that “speculation and anticipation … should be strongly deprecated.”13   As 
late as 1957, when he was invited to give the Department of Health, Education, and Welfare’s 
prestigious Dyer Lecture concerning his work with viruses, including animal cancer viruses, 
Richard Shope worried that “the address is written for a professional audience of knowledgeable 
scientists,” and resisted passing a copy to the New York Times on the grounds that it might cause 
“alarmist headlines if the material is lifted out of context.”14 
Indeed, negotiating the relationship between cancer research and the public was one of 
the major points of definition for what it means to conduct serious scientific research.  Shortly 
after its founding, the director of MSKCC, Cornelius Rhodes, and its main patron, Alfred Sloan, 
engaged in a long discussion of the uses of media in discussing MSKCC, particularly film.    
These discussions focused on the tension between public education about cancer research in 
general and promotion of MSKCC in particular.  For example, one scientist worried that the film 
storyboard presented a picture that should be “less rosy.”  Ultimately, it appears that the film 
floundered between appeasing its prospective public and MSKCC’s concern for scientific 
probity.
15
   
The papers of Memorial Hospital (which later merged with the Sloan-Kettering Institute) 
also show a keen awareness of the power, possibilities, and peril of publicity.  Memorial Hospital 
depended on fundraising and philanthropy to support its work, so monitoring and burnishing its 
public image was important work, work reflected in its archives.  In the mid-1950s Memorial 
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Hospital produced a circular on “Principles of Professional Conduct Which Influence 
Memorial’s Center Mechanics for Publicity.”  The memo cited the dual obligations to serve a 
“common good” by supplying the public with information quickly, versus the appearance of 
seeking “self-publicity.”  Ultimately, the memo conveyed the sentiment that “science-writers are 
here to stay … more can be gained by working with them than against them … work more 
closely with the men and women who write about us.”16   
Regarding the contributions that MSKCC had made to chemotherapy, in 1956 its 
president wrote that “the nature of the story is such that it is not easy to get it across to the 
general public.  There has been no single sudden discovery or dramatic event.”  Nonetheless, “if 
we do not pick up this story now it will quickly merge into the background history of medical 
science.”17  Alfred Sloan endorsed this idea, urging that these advances be reported “forcibly” to 
the public to convey the impression “that we are progressive and making progress.”18  This 
exchange shows that despite an affective posture of aloofness, cancer researchers and 
administrators could be deeply concerned with the public reception of their work. 
The clippings books maintained by the Hospital, spanning most of the twentieth century, 
constitute a fascinating resource for tracing the public reception and interpretation of cancer 
research.  In particular, where theories of the viral cause of cancer might have been thought to 
inspire panic, there was as much enthusiasm for the possibility of developing a vaccine.  The 
work of MSKCC Charlotte Friend—who had not only identified a mouse leukemia virus, but 
claimed to have successfully inoculated other mice against it, drew considerable attention just 
after the successful release of the Salk Polio vaccine.
19
  In 1956 the New Orleans Times-
Picayune carried the headline “Virus Seen as Possible Human Leukemia Cause.”20  The New 
York Herald Tribune hailed Friend’s discovery as a “Step Toward a Vaccine” despite the 
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observation that these “cancer viruses” did not bear any relationship to the viral causes of 
diseases such as measles, polio, or chickenpox.
21
    In 1960 researchers at the MSKCC, Henle 
Toolan and Alice Moore, were involved in the possible isolation of a human cancer virus.  
Thanks to the clippings books it is possible to ascertain not only where the stories appeared, but 
in this instance—where the stories were syndicated—giving a different sense of the reception of 
caner virus work than one would gain from the scientific press or even searches of digitized 
national newspapers.  Coverage of Toolan and Moore’s work appeared in local papers from New 
Jersey out to Oklahoma.
22
 
Public, or at least press interest in the possibility of a cancer vaccine continued through 
the sixties and into the seventies.  Writing of Friend’s earlier research, the 1963 Sloan-Kettering 
Institute Progress Report noted that the “relationship between virus and cell during the stages of 
leukemia development would seem to hold the key for successful vaccination against leukemia 
virus.”23  Heralding the National Cancer Institute’s Special Virus Leukemia program in 1964 the 
Ladies Home Journal reported that “mounting evidence suggests that cancer may be caused by a 
virus.  Scientists across the country are engaged in a massive research program seeking a medical 
breakthrough like the one that finally conquered polio.”24  In 1965 Business Week wrote that 
“leukemia may be the first form [of cancer] to be brought under control.  Tests of vaccine have 
already begun.”25  The Medical World News wrote of efforts aimed at “Coaxing Leukemia Virus 
Suspect out of Hiding” in 1970, just as legislation to establish a formal “War on Cancer” was 
under consideration.
26
  While from the perspective of many cancer researchers and virologists, 
the possibility of identifying a leukemia virus or developing a vaccine remained slight, this 
coverage reminds us that the momentum of cancer research often lay as much with its public 
patrons as with its professional scientists and medical professionals. 
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Vaccination efforts had a darker side too.  One of the most discussed instances involved 
the efforts of the immunologist Chester Southham to inoculate convicts at an Ohio Penitentiary 
against infection with cancer.  While this episode has often been recalled as a source of 
controversy, the press clippings collected surrounding the beginning of this project place its 
origins in a different light.
27
  Southam’s initial work in 1956 was hailed by many newspapers, 
such as the Citizen (Columbus, Ohio), with the announcement that ninety-six inmates had 
“volunteered” to be “injected with cancer” as “Enthusiastic Cancer Guinea Pigs.”  Although it 
was years from verification, the possibility of such a vaccine was discussed favorably by 
virologists working at the MSKCC.
28
  Later in the 1960s, similar tumor immunology 
experiments carried out by Southam with New York area patients (where consent was never 
sought) faced legal challenge and public censure; and Southam’s medical license was suspended 
for a year.
29
  Despite this ruling, memoranda from the MSKCC’s board of Scientific Advisors 
show his attempts to continue support for his Ohio research in the midst of this controversy.  
Southam wrote to the director that, “funds should be available for follow-up of past participants 
in the Ohio Penitentiary studies in order to salvage as much as possible from the curtailed 
research programs.”  Southam expressed frank astonishment that his work was subject to critical 
review, claiming that it represented a “retreat by our Institute from the responsibility of 
leadership … it is possible that [the board of Scientific Advisors] do not realize what a 
detrimental effect their decisions can have.”30  It appeared, in the view of one of Southam’s 
collaborating doctors in Ohio, that “the climate favoring suits … has changed considerably … 
since the notoriety surrounding the affair in New York state.”  However, the doctor hoped that 
following the abatement of publicity, the administrators of the MSKCC would “see their way 
clear to a more reasonable amount of support for this very exciting and interesting project.”31 
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In the context of other inquiries into the ethics of human experimentation in the United 
States, this exchange buttresses the claim made by historians of bioethics that the medical 
community did not move as a group to a particular standard of patient rights and informed 
consent after Nuremburg.  Rather, along with the Tuskegee Experiment and other work with 
cancer patients, many doctors assumed the human experiments they were carrying out in the 
aftermath of the Second World War were not ethically suspect.
32
  Indeed, the positive press 
coverage given to the initial trial suggests that this type of research warranted mainstream 
endorsement even after the revelations regarding the acts of Nazi doctors at the Nuremburg 
trials.  
These are only some of the initial findings and observations I have arrived at after my 
research at the Rockefeller Archive Center and I expect other themes to emerge as well as I 
examine these documents further and integrate them with the research I have conducted in the 
papers of the National Cancer Institute and other cancer virus researchers.  In closing, I would 
like to extend my thanks for the support which enabled me to undertake this research, and the 
welcoming and collegial environment which I found at the RAC during this research. 
 
 
 
 
 
 
Editor's Note: This research report is presented here with the author’s permission but should not be cited or 
quoted without the author’s consent.  
Rockefeller Archive Center Research Reports Online is a periodic publication of the Rockefeller 
Archive Center. Edited by Erwin Levold, Research Reports Online is intended to foster the network of 
scholarship in the history of philanthropy and to highlight the diverse range of materials and subjects covered 
in the collections at the Rockefeller Archive Center. The reports are drawn from essays submitted by 
researchers who have visited the Archive Center, many of whom have received grants from the Archive Center 
to support their research.  
The ideas and opinions expressed in this report are those of the author and are not intended to 
represent the Rockefeller Archive Center. 
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